Flonase Indirect Purchasers Sue SmithKline Beecham
Legal problems continue to stack up against SmithKline Beecham Corp., which faces another proposed class action for allegedly stalling the approval of a generic version of Flonase, the drugmaker's blockbuster nasal...To view the full article, register now.
Already a subscriber? Click here to view full article